Press Releases

Rho Chief Operating Officer Tara Gladwell Receives Triangle Business Journal 2022 Women in Business Award

February 10, 2022

Awards program recognizes dynamic and outstanding leaders

Research Triangle Park, NC – February 10, 2022 –Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, today announced that its Chief Operating Officer (COO), Tara Gladwell, has received a 2022 Women in Business Award from the Triangle Business Journal (TBJ).

The award recognizes Triangle-area women who are outstanding, accomplished leaders in business and/or community service. Twenty-eight winners were selected from around 200 entries and will be recognized on March 24 at an awards luncheon in Cary, North Carolina. Winners will be profiled in the March 25 subscriber edition of the TBJ.[1]

Ms. Gladwell was appointed as COO of Rho in May 2021. As the first person from outside the company’s founding family to hold a C-suite position, she provides strategic direction and oversight to business development, clinical trials operations, regulatory strategy and submissions, and biometrics. Prior to her promotion, she most recently served as Senior Vice President of Operations in her 20-year company tenure.

“Tara has been instrumental in building the clinical operations and business development functions at Rho, and she played a vital role in Rho’s first-ever global acquisition late last year,” said Dr. Laura Helms Reece, CEO of Rho. “Her industry knowledge and ability to get things done—both with hands-on effort and by inspiring others—make her worthy of this great achievement.”

About Rho

Rho is a global, privately held contract research organization (CRO) headquartered in Research Triangle Park, a biotech hub in North Carolina, US. Rho provides a full range of drug development services, from program strategy through to clinical trials and marketing applications. For more than 36 years, Rho has been a trusted partner to some of the most innovative pharmaceutical, biotechnology and medical device companies as well as academic and government organizations. Dedicated to service excellence and cross-functional collaboration, Rho’s therapeutic expertise, employee focus and commitment to strong site relationships change what it means to work with a CRO – accelerating time to market, maximizing ROI, and delivering consistent, smarter and more efficient programs. Experience Rho by following the company on FacebookLinkedInTwitter, and Instagram.



Kelly Maicon (on behalf of Rho)


m: 919.741.9784